181 related articles for article (PubMed ID: 8423099)
1. Cellular and humoral immune responses induced in cattle by vaccination with Babesia divergens culture-derived exoantigens correlate with protection.
Valentin A; Precigout E; L'Hostis M; Carcy B; Gorenflot A; Schrevel J
Infect Immun; 1993 Feb; 61(2):734-41. PubMed ID: 8423099
[TBL] [Abstract][Full Text] [Related]
2. Identification of major Babesia divergens polypeptides that induce protection against homologous challenge in gerbils.
Gorenflot A; Precigout E; Bissuel G; Lecointre O; Brasseur P; Vidor E; L'Hostis M; Schrevel J
Infect Immun; 1990 Dec; 58(12):4076-82. PubMed ID: 2254031
[TBL] [Abstract][Full Text] [Related]
3. Babesia divergens vaccine.
Gorenflot A; Precigout E; Valentin A; Bissuel G; Carcy B; Brasseur P; Moreau Y; Schrevel J
Mem Inst Oswaldo Cruz; 1992; 87 Suppl 3():279-81. PubMed ID: 1343703
[TBL] [Abstract][Full Text] [Related]
4. A 37-kilodalton glycoprotein of Babesia divergens is a major component of a protective fraction containing low-molecular-mass culture-derived exoantigens.
Carcy B; Precigout E; Valentin A; Gorenflot A; Schrevel J
Infect Immun; 1995 Mar; 63(3):811-7. PubMed ID: 7868251
[TBL] [Abstract][Full Text] [Related]
5. Analysis of immune responses of different hosts to Babesia divergens isolates from different geographic areas and capacity of culture-derived exoantigens to induce efficient cross-protection.
Precigout E; Gorenflot A; Valentin A; Bissuel G; Carcy B; Brasseur P; Moreau Y; Schrevel J
Infect Immun; 1991 Aug; 59(8):2799-805. PubMed ID: 1713201
[TBL] [Abstract][Full Text] [Related]
6. Exoantigens of an attenuated strain of Babesia bovis used as a vaccine against bovine babesiosis.
Patarroyo JH; Prates AA; Tavares CA; Mafra CL; Vargas MI
Vet Parasitol; 1995 Oct; 59(3-4):189-99. PubMed ID: 8533277
[TBL] [Abstract][Full Text] [Related]
7. Protective efficacy of Babesia gibsoni culture-derived exoantigens against the challenge infection in dogs.
Sunaga F; Arai S; Itoh S; Taharaguchi S
Parasitol Res; 2014 May; 113(5):1681-6. PubMed ID: 24535736
[TBL] [Abstract][Full Text] [Related]
8. An immunisation trial with in vitro produced Babesia bigemina exoantigens.
Beniwal RP; Nichani AK; Rakha NK; Sharma RD; Sarup S
Trop Anim Health Prod; 1997 Nov; 29(4 Suppl):124S-126S. PubMed ID: 9512758
[TBL] [Abstract][Full Text] [Related]
9. Culture-derived Babesia orientalis exoantigens used as a vaccine against buffalo babesiosis.
Zhao JL; Liu ZL; Yao BA; Ma LH
Parasitol Res; 2002 May; 88(13 Suppl 1):S38-40. PubMed ID: 12051606
[TBL] [Abstract][Full Text] [Related]
10. Vaccination of dogs against heterologous Babesia canis infection using antigens from culture supernatants.
Schetters TP; Kleuskens JA; Scholtes NC; Gorenflot A; Moubri K; Vermeulen AN
Vet Parasitol; 2001 Sep; 100(1-2):75-86. PubMed ID: 11522408
[TBL] [Abstract][Full Text] [Related]
11. Babesia divergens apical membrane antigen-1 (BdAMA-1): A poorly polymorphic protein that induces a weak and late immune response.
Moreau E; Bonsergent C; Al Dybiat I; Gonzalez LM; Lobo CA; Montero E; Malandrin L
Exp Parasitol; 2015 Aug; 155():40-5. PubMed ID: 25956948
[TBL] [Abstract][Full Text] [Related]
12. Live and soluble antigens for cattle protection to Babesia bigemina.
Echaide IE; de Echaide ST; Guglielmone AA
Vet Parasitol; 1993 Dec; 51(1-2):35-40. PubMed ID: 8128585
[TBL] [Abstract][Full Text] [Related]
13. Strain variation limits protective activity of vaccines based on soluble Babesia canis antigens.
Schetters TH; Kleuskens J; Scholtes N; Bos HJ
Parasite Immunol; 1995 Apr; 17(4):215-8. PubMed ID: 7542765
[TBL] [Abstract][Full Text] [Related]
14. Improved disease resistance after Babesia divergens vaccination.
Edelhofer R; Kanout A; Schuh M; Kutzer E
Parasitol Res; 1998; 84(3):181-7. PubMed ID: 9521006
[TBL] [Abstract][Full Text] [Related]
15. Vaccination against babesiosis using recombinant GPI-anchored proteins.
Nathaly Wieser S; Schnittger L; Florin-Christensen M; Delbecq S; Schetters T
Int J Parasitol; 2019 Feb; 49(2):175-181. PubMed ID: 30684517
[TBL] [Abstract][Full Text] [Related]
16. Immunoprophylactic control of bovine babesiosis: role of exoantigens of Babesia.
Montenegro-James S
Trans R Soc Trop Med Hyg; 1989; 83 Suppl():85-94. PubMed ID: 2696166
[TBL] [Abstract][Full Text] [Related]
17. Application of exoantigens of Babesia and Plasmodium in vaccine development.
James MA
Trans R Soc Trop Med Hyg; 1989; 83 Suppl():67-72. PubMed ID: 2696163
[TBL] [Abstract][Full Text] [Related]
18. Immunity against Babesia rossi infection in dogs vaccinated with antigens from culture supernatants.
Schetters TP; Strydom T; Crafford D; Kleuskens JA; van de Crommert J; Vermeulen AN
Vet Parasitol; 2007 Mar; 144(1-2):10-9. PubMed ID: 17056181
[TBL] [Abstract][Full Text] [Related]
19. Vaccination of older Bos taurus bulls against bovine babesiosis.
Shkap V; Leibovitz B; Krigel Y; Hammerschlag J; Marcovics A; Fish L; Molad T; Savitsky I; Mazuz M
Vet Parasitol; 2005 May; 129(3-4):235-42. PubMed ID: 15845278
[TBL] [Abstract][Full Text] [Related]
20. Induction of protective immunity to Babesia divergens in Mongolian gerbils, Meriones unguiculatus, using culture-derived immunogens.
Winger CM; Canning EU; Culverhouse JD
Vet Parasitol; 1987 Dec; 26(1-2):43-53. PubMed ID: 3439004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
